Activation of Human Macrophage Fungistatic Activity Against Histoplasma capsulatum Upon Adherence to Type 1 Collagen Matrices

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1779-1786

  Newman, Simon L ^a   Gootee, Lisa ^a   Kidd, Chris ^a   Ciraolo, Georgianne M ^a   Morris, Randal ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; IRON;

ARTICLE; CELL ADHESION; GEL; GROWTH, DEVELOPMENT AND AGING; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; IMMUNOLOGY; INTRACELLULAR FLUID; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; PHAGOSOME; PHYSIOLOGY;

CELL ADHESION; COLLAGEN; CYTOKINES; GELS; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; INTRACELLULAR FLUID; IRON; MACROPHAGE ACTIVATION; MACROPHAGES; PHAGOSOMES;

EID: 0031568541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Reddy, P., D. F. Gorelick, C. A. Brasher, and H. Larsh. 1970. Progressive disseminated histoplasmosis as seen in adults. Am. J. Med. 48:629.
2. Smith, J. W., and J. P. Utz. 1972. Progressive disseminated histoplasmosis: a prospective study of 26 patients. Ann. Intern. Med. 76:557.
3. Davies, S. F., M. Khan, and G. A. Sarosi. 1978. Disseminated histoplasmosis in immunologically suppressed patients: occurrence in a nonendemic area. Am. J. Med. 64:94.
4. Kaufman, C. A., K. S. Israel, J. W. Smith, A. C. White, J. Schwarz, and G. F. Brooks. 1978. Histoplasmosis in immunosuppressed patients. Am. J. Med. 64: 923.
5. Wheat, L. J., T. G. Slama, J. A. Norton, R. B. Kohler, H. E. Eitze, M. L. V. French, and B. Sathapatayavongs. 1982. Risk factors for disseminated or fatal histoplasmosis. Ann. Intern. Med. 96:159.
6. Wheat, L. J., E. J. Smith, B. Sathapatyavongs, B. Batteiger, R. S. Filo, S. B. Leapman, and M. V. French. 1983. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch. Intern. Med. 143:703.
7. Graybill, J. R. 1988. Histoplasmosis in AIDS. J. Infect. Dis. 158:623.
8. Kurtin, P. J., D. S. McKinsey, M. R. Gupta, and M. Driks. 1990. Histoplasmosis in patients with acquired immunodeficiency syndrome. Am. J. Clin. Pathol. 93: 367.
9. Deepe, G. S., and W. E. Bullock. 1992. Histoplasmosis: a granulomatous inflammatory response. In Inflammation: Basic Principles and Clinical Correlates. 2nd Ed. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 943.
10. Baughman, R. P., C. K. Kim, A. Vinegar, D. E. Hendricks, D. J. Schmidt, and W. E. Bullock. 1986. The pathogenesis of experimental pulmonary histoplasmosis: correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am. Rev. Respir. Dis. 134:771.
11. Newman, S. L., and W. E. Bullock. 1993. Interaction of Histoplasma capsulatum yeasts and conidia with human and animal macrophages. In Macrophage Pathogen Interactions. B. S. Zwilling and T. Eisenstein, eds. Marcel Dekker, Inc., New York, pp. 517-532.
12. Wu-Hsieh, B., and D. H. Howard. 1987. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect. Immun. 55:1014.
13. Lane, T. E., B. A. Wu-Hsieh, and D. H. Howard. 1993. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect. Immun. 4:1468.
14. Smith, J. G., D. M. Magee, D. M. Williams, and J. R. Graybill. 1990. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162:1349.
15. Wu-Hsieh, B. A., G. Lee, M. Franco, and F. M. Hofman. 1992. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect. Immun. 60:4230.
16. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder, 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785.
17. Fleischmann, I., B. Wu-Hsieh, and D. H. Howard. 1990. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ. J. Infect. Dis. 161:143.
18. Newman, S. L., and L. Gootee. 1992. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immun. 11:4593.
19. Newman, S. L., and M. A. Tucci. 1990. Regulation of human monocyte/macrophage function by extracellular matrix: adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J. Clin. Invest. 3:703.
20. Byrd, T. F., and M. A. Horwitz. 1991. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J. Clin. Invest. 88:351.
21. Newman, S. L., L. Gootee, G. Brunner, and G. S. Deepe, Jr. 1994. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest. 4:1422.
22. Gmelig-Meyling, F., and T. A. Waldman. 1980. Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J. Immunol. Methods 33:1.
23. Newman, S. L., C. Bucher, J. Rhodes, and W. E. Bullock. 1990. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest. 85:223.
24. Newman, S. L., L. Gootee, R. Morris, and W. E. Bullock. 1992. Digestion of Histoplasma capsulatum yeasts by human macrophages. J. Immunol. 149:574.
25. Worsham, P., and W. E. Goldman. 1988. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J. Med. Vet. Mycol. 26:137.
26. Newman, S. L., L. Gootee, C. Bucher, and W. E. Bullock. 1991. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect. Immun. 2:737.
27. Karnovsky, M. J. 1971. Use of ferrocyanide-reduced osmium tetroxide in electron microscopy. J. Cell. Biol 51:146a.
28. Lane, T. E., B. A. Wu-Hsieh, and D. H. Howard. 1991. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun. 7:2274.
29. Jacobs, A. 1977. Low molecular weight intracellular iron transport compounds. Blood 50:433.
30. Dautry-Varsat, A., A. Ciechanover, and H. F. Lodish. 1983. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acacl. Sci. USA 80:2258.
31. Baynes, R., G. Bukofzer, T. Bothwell, W. Bezwoda, and B. Macfarlane. 1987. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. Eur. J. Cell Biol. 43:372.
32. Bates, G. W., and J. Wemicke. 1971. The kinetics and mechanism of iron (III) exchange between chelates and transferrin. J. Biol. Chem. 246:3679.
33. Pakianathan, D. R. 1995. Extracellular matrix proteins and leukocyte function. J. Leukocyte Biol. 57:699.
34. 2 and interleukin 1 production by human monocyte macrophages. FEBS Lett. 198:208.
35. Eierman, D. F., C. E. Johnson, and J. S. Haskill. 1989. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142:1970.
36. Kaplan, G. 1983. In-vitro differentiation of human monocytes. Monocytes cultured on glass are cytotoxic to tumor cells but monocyte cultured on collagen are not. J. Exp. Med. 157:2061.
37. Newman, S. L., L. Gootee, V. Stroobant, H. van der Goot, and J. R. Boelaert. 1995. Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine. Antimicrob. Agents Chemother. 39:1824.
38. Lane, T. E., G. C. Otero, B. A. Wu-Hsieh, and D. H. Howard. 1994. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun. 4:1478.
39. Lane, T. E., B. A. Wu-Hsieh, and D. H. Howard. 1994. Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect. Immun. 5:1940.
40. Eissenberg, L. P., P. H. Schlesinger, and W. E. Goldman. 1988. Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J. Leukocyte Biol. 43:483.
41. Taylor, M. L., M. E. Espinosa-Schoelly, R. Iturbe, B. Rico, J. Casasola, and F. Goodsaid. 1989. Evaluation of phagolysosome fusion in acridine orange stained macrophages infected with Histaplasma capsulatum. Clin. Exp. Immunol. 75:466.
42. Eissenberg, L. G., W. E. Goldman, and P. H. Schlesinger. 1993. Histoplasma capsulatum modulates the acidification of phagolysosomes. J. Exp. Med. 6:1605.